<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03530241</url>
  </required_header>
  <id_info>
    <org_study_id>IFC4</org_study_id>
    <nct_id>NCT03530241</nct_id>
  </id_info>
  <brief_title>Fluorescent Cholangiography and Bile Duct Stones</brief_title>
  <official_title>Sensitivity and Specificity of Fluorescent Cholangiography to Detect Bile Duct Stones in Patients Undergoing Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background. X-ray cholangiography has a high sensitivity and specificity of detecting bile
      duct stones and is the gold standard. There are no studies describing the sensitivity and
      specificity of IFC for bile duct stone detection.

      Research question. What is the sensitivity of IFC to visualize bile duct stones? Method.
      Prospective study with 40 patients undergoing planned laparoscopic cholecystectomy with
      preoperative magnetic resonance cholangiopancreatography (MRCP) (gold standard) and
      intraoperative IFC, X-ray cholangiography and choledochuscopy in that order.

      Primary outcome. Sensitivity of visualization of bile duct stone by fluorescent
      cholangiography and secondary outcome is visualization of anatomy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity</measure>
    <time_frame>120mins</time_frame>
    <description>Sensitivity and specificity of visualization of bile duct stones by intraoperative fluorescent cholangiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visualization</measure>
    <time_frame>120mins</time_frame>
    <description>Visualization of the extrahepatic bile ducts</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gall Stones, Common Bile Duct</condition>
  <arm_group>
    <arm_group_label>MRCP positive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>MRCP negative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Presence of bile duct stones</intervention_name>
    <description>MRCP verified gall stones in the bile ducts</description>
    <arm_group_label>MRCP positive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Non-presence of bile duct stones</intervention_name>
    <description>MRCP without bile duct stones</description>
    <arm_group_label>MRCP negative</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suspected of having bile duct stones by either blood samples, MRCP or medical
             history

          -  Patient age â‰¥ 18 years

        Exclusion Criteria:

          -  Open cholecystectomy (including conversion from laparoscopic to open)

          -  Acute operation (e.g. acute cholecystitis/cholangitis/severe pancreatitis)

          -  Allergy towards iodine or indocyanine green

          -  Liver or renal insufficiency

          -  Thyrotoxicosis

          -  Cholecystectomy not the primary surgical procedure

          -  Pregnancy or lactation

          -  Legally incompetent for any reason

          -  Withdrawal of inclusion consent at any time
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars L Lehrskov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hvidovre University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lars L Lehrskov, MD</last_name>
    <phone>+4538621937</phone>
    <email>lars@lartin.eu</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2018</study_first_submitted>
  <study_first_submitted_qc>May 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2018</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Lars Lehrskov-Schmidt</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>fluorescence</keyword>
  <keyword>cholangiography</keyword>
  <keyword>cholecystectomy, laparoscopic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

